Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Mar 1;18(5):1309-20.
doi: 10.1093/emboj/18.5.1309.

The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop

H Yasukawa  1 , H Misawa, H Sakamoto, M Masuhara, A Sasaki, T Wakioka, S Ohtsuka, T Imaizumi, T Matsuda, J N Ihle, A Yoshimura
Affiliations

The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop

H Yasukawa et al. EMBO J. .

Abstract

The Janus family of protein tyrosine kinases (JAKs) regulate cellular processes involved in cell growth, differentiation and transformation through their association with cytokine receptors. However, compared with other kinases, little is known about cellular regulators of the JAKs. We have recently identified a JAK-binding protein (JAB) that inhibits JAK signaling in cells. In the studies presented here we demonstrate that JAB specifically binds to the tyrosine residue (Y1007) in the activation loop of JAK2, whose phosphorylation is required for activation of kinase activity. Binding to the phosphorylated activation loop requires the JAB SH2 domain and an additional N-terminal 12 amino acids (extended SH2 subdomain) containing two residues (Ile68 and Leu75) that are conserved in JAB-related proteins. An additional N-terminal 12-amino-acid region (kinase inhibitory region) of JAB also contributes to high-affinity binding to the JAK2 tyrosine kinase domain and is required for inhibition of JAK2 signaling and kinase activity. Our studies define a novel type of regulation of tyrosine kinases and might provide a basis for the design of specific tyrosine kinase inhibitors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4379-83 - PubMed
    1. Nature. 1998 Sep 17;395(6699):244-50 - PubMed
    1. J Biol Chem. 1986 Jan 25;261(3):989-92 - PubMed
    1. Science. 1987 Dec 18;238(4834):1726-8 - PubMed
    1. Science. 1991 Jul 26;253(5018):414-20 - PubMed

Publication types

MeSH terms